Mark Lee
Senior Vice President, Corporate Management and Communications of HodgeMed
Replay available
HUTCHMED (China) Limited (NASDAQ: HCM) Q2 2024 earnings conference call, held 2024-07-31. Replay captured from the company's public earnings webcast.

Senior Vice President, Corporate Management and Communications of HodgeMed
Chief Executive Officer and Chief Scientific Officer
Chief Financial Officer
Head of Manufacturing and Global Supply Chain
Head of Late-Stage Pipeline Development
Analyst, Kent Hall
Analyst, Goldman Sachs
Analyst, PennMirror-Gordon
Watch the replay and follow the connected company analysis, news, and investor updates for Hutchmed (china) Limited.
WEBVTT 00:00:00.029 -- 00:00:03.531 and thank you for standing by. Welcome to HodgeMed 2023 00:00:03.531 -- 00:00:06.473 Full-Year Financial Results Conference Call. 00:00:06.473 -- 00:00:09.595 At this time, all participants are in a listen-only mode. 00:00:09.595 -- 00:00:13.837 After the speaker's presentation, there will be a question and answer session. 00:00:13.837 -- 00:00:18.440 To ask a question during the session, you need to press star 11 on your telephone. 00:00:18.440 -- 00:00:22.142 You'll then hear an automated message advising your hand is raised. 00:00:22.142 -- 00:00:25.327 Please be advised that today's conference is being recorded. 00:00:25.327 -- 00:00:28.350 I'd now like to pass the call over to your first speaker today, Mr. 00:00:28.350 -- 00:00:33.193 Mark Lee, Senior Vice President, Corporate Management and Communications of Hachmed. 00:00:33.193 -- 00:00:35.856 Thank you. Please go ahead. 00:00:35.856 -- 00:00:40.760 Thank you, Desmond. Welcome, everybody. Good morning, good afternoon, good evening. 00:00:40.760 -- 00:00:46.084 Just a brief message as usual. The performance results and operations of Hachmed 00:00:46.084 -- 00:00:51.048 are historic in nature, and past performance is no guarantee of the future. 00:00:51.048 -- 00:00:55.004 We've got forward-looking statements, which means Within the meaning of the safe harbor 00:00:55.004 -- 00:00:58.544 provisions of the US SEC, 00:00:58.685 -- 00:01:04.188 this presentation is for investors only, and information on pharmaceuticals 00:01:04.188 -- 00:01:07.930 are not intended as advertising or medical advice. 00:01:07.930 -- 00:01:12.993 This presentation contains statistical and other third-party data which we 00:01:12.993 -- 00:01:15.474 have not independently verified, 00:01:15.474 -- 00...